Givaudan | GIVN - Current Liabilities


Givaudan reported CHF2.35B in Current Liabilities for its fiscal semester ending in December of 2025.





Current Liabilities Change Date
Air Liquide EUR 11.46B 2.7B Jun/2026
Akzo Nobel EUR 4.31B 77M Jun/2026
Anheuser-Busch USD 33.48B 999M Jun/2026
Arkema EUR 3.16B 1.01B Jun/2026
Associated British Foods GBP 4.04B 321M Dec/2025
BASF EUR 20.91B 1.26B Jun/2026
Bayer EUR 32.27B 1.19B Jun/2026
Beiersdorf EUR 3.51B 261M Dec/2025
British American Tobacco GBP 14.28B 246M Jun/2026
Covestro EUR 3.87B 299M Dec/2025
Croda International GBP 547.7M 209.7M Dec/2024
Danone EUR 16.6B 1.97B Jun/2026
Diageo GBP 10.73B 1.05B Jun/2026
Fresenius EUR 9.07B 468M Jun/2026
Fresenius Medical Care EUR 7.18B 448.03M Jun/2026
Givaudan CHF 2.35B 422M Dec/2025
Heineken EUR 16.29B 2.36B Jun/2026
Henkel EUR 9.94B 1.53B Jun/2026
International Flavors Fragrances USD 4.41B 765M Jun/2026
Johnson Matthey GBP 2.53B 211M Jun/2026
Kerry EUR 1.73B 75.7M Jun/2026
Lonza CHF 3.57B 421M Dec/2025
L'Oréal EUR 18.55B 3.18B Jun/2026
Merck EUR 8.12B 1.22B Jun/2026
Nestle CHF 45.29B 4.6B Jun/2026
Pernod Ricard EUR 5.01B 583M Jun/2026
Reckitt Benckiser GBP 7.94B 901M Dec/2024
SGS CHF 2.53B 53M Dec/2024
Sika AG CHF 3.53B 730M Dec/2025
Solvay EUR 1.78B 6M Jun/2026
Tate & Lyle GBP 493M 82M Jun/2026
Umicore EUR 4.55B 293.7M Jun/2026
Victrex GBP 80.5M 18.9M Jun/2026